ChiCTR2100052080
尚未开始
/
/
/
2021-10-16
/
/
Diabetes
Lay health worker as an example of medical task-shifting: Design of a pragmatic randomized controlled trial for diabetes prevention in people living in inadequate housing
Lay health worker intervention on diabetes management
This is a pragmatic, wait-list randomized controlled trial to evaluate the impact of lay health worker intervention on the incidence and disease management of diabetes among people living in socially-inappropriate households. We hypotheses that the lay health worker intervention could significantly improve disease prognosis of people with risk to develop diabetes, who are living in socially-inappropriate housing using an example of Hong Kong Chinese population.
连续入组
Ⅰ期
N/A
N/A
The Jockey Club Charity Trust
/
222
/
2021-10-16
2022-10-31
/
This trial includes the major caregiver of households living in sub-divided flat units who are 1) responsible for the food preparation of the family, 2) ethnically Chinese and aged >= 18, 3) identified with >= 1 risk factor or symptoms for T2DM according to the Hong Kong Reference Framework for Diabetes Care for Adults in Primary Care Settings; 4) HKID holders, 5) able to communicate in Chinese or English; and 6) able to give consent. People who are cognitively incompetent, and whose co-living family members have already enrolled in this trial will be excluded. Hong Kong Reference Framework for Diabetes Care for Adults in Primary Care Settings is a well-established guideline adopted I in the primary care services in Hong Kong for screening people who are at risk to T2DM[15]. Eligible participants will be invited to participant in this study through partnering non-profit organizations (NPOs) that provided care services to low-income families living in socially-inappropriate housings in Hong Kong. Participants who are interested in the study will be invited to an initial health assessment, where a study information sheet and the ethics consent form will be explained to the participants in person, and participants will be allowed to consider their participation before offering consent.;
登录查看People who are incapable to offer consent will be excluded.;
登录查看N/A
/
PDL1 三阴性乳腺癌 atezolizumab
BioArtMED2025-06-21
糖尿病 GLP-1/GIP
恒瑞医药2025-06-21
肥胖 Wegovy
一度医药2025-06-21
ADA 糖尿病
箕星药业科技2025-06-21
乙肝 乙肝疫苗
肝脏时间2025-06-21
药物临床试验
Insight数据库2025-06-21
B细胞恶性肿瘤 自身免疫性疾病 Capstan
博生吉细胞研究2025-06-21
结节性硬化症 三叉神经痛 BD项目
美柏资本2025-06-21
正大天晴药业集团2025-06-21